Science, Health and Development: The Role of Genomics and Biotechnology in Paraguay

Abstract

Paraguay faces a silent but decisive choice: to remain a consumer of scientific knowledge or to become a country capable of producing it. At this turning point, genomics and biotechnology are not academic luxuries or laboratory curiosities; they are strategic tools for national development and part of the same scientific and technological ecosystem.

Genomics makes it possible to understand the genetic information of living organisms, while biotechnology transforms that knowledge into concrete applications for health, production, and innovation. In other words, genomics generates strategic knowledge, and biotechnology converts it into solutions with direct impact on society and the economy.

In the field of human health, these disciplines enable progress toward more accurate diagnostics, more effective treatments, and a more preventive and personalized medicine. They also strengthen the capacity to respond to emerging diseases and future health challenges.

In a country with a strong agricultural and livestock-based economy such as Paraguay, the integration of genomics and biotechnology is also of enormous value for agronomy and animal production. Their applications can improve the genetic quality of crops and livestock, increase productivity, optimize resistance to diseases and adverse climatic conditions, strengthen food security, and make national production more competitive in international markets.

Currently, funding opportunities and projects linked to these areas are being promoted, representing an important opportunity for the country. However, much of society still remains unaware of the true strategic scope of genomics and biotechnology, as well as their potential to generate scientific development, productive innovation, and technological independence.

As an LMIC (Low- and Middle-Income Country), Paraguay also faces structural challenges that limit scientific and technological development: dependence on imported reagents and supplies, unequal access to high-cost technologies, discontinuous research funding, scientific brain drain, limited articulation between science and industry, scarce technology transfer, and reduced local biotechnological manufacturing capacity. Added to this are emerging global threats such as pandemics, antimicrobial resistance, and the need for sovereignty over strategic genomic and biological data. In today’s scientific landscape, technological dependence is no longer only an economic limitation; it is also a sanitary, productive, and geopolitical vulnerability.

Countries that have invested in these disciplines are building scientific sovereignty, innovation capacity, and resilience against health, environmental, and productive crises. Those that fail to do so deepen their technological dependence and limit their possibilities for autonomous development.

Paraguay has human talent, scientific institutions, and accumulated experience. However, transforming this potential into real capacity requires sustained investment, articulation between science, health, and production, and a State policy that understands knowledge as strategic infrastructure for development.

Some priority actions could include:

• Strengthening national genomics and sequencing platforms aimed at epidemiological surveillance, antimicrobial resistance, animal health, and food security.

• Developing local biotechnology capacities and production of strategic supplies, reducing dependence on imported reagents and technologies.

• Promoting advanced training programs and scientific talent retention, fostering the creation of critical mass in highly complex technological areas.

• Encouraging partnerships among universities, the health system, the productive sector, and State agencies to accelerate technology transfer and applied innovation.

• Creating national policies for genomic and biological data sovereignty, ensuring that strategic information generated in the country contributes primarily to national development.

• Integrating One Health approaches into Science, Technology, and Innovation projects, linking human health, animal health, and the environment to address challenges such as emerging pandemics and antimicrobial resistance.

These actions would not only strengthen national scientific capacity but also position Paraguay more competitively within the knowledge economy of the 21st century.

Science can no longer continue to be viewed as a marginal expense. In the 21st century, science is a form of sovereignty. And the integration of genomics and biotechnology represents a historic opportunity for Paraguay to strengthen its research, innovation, and development capacities for the benefit of the entire population.